Swine Dysentery (Brachyspira)

Swine dysentery is a severe mucohemorrhagic diarrheal disease of pigs caused primarily by the anaerobic spirochete bacterium Brachyspira hyodysenteriae. This economically significant disease affects the large intestine, specifically the cecum and colon, causing characteristic bloody mucoid diarrhea that distinguishes it from other enteric conditions affecting swine. The disease has been recognized in pig populations worldwide for over a century and remains one of the most costly enteric diseases in commercial swine production despite advances in understanding its epidemiology and control.

Swine dysentery primarily affects growing and finishing pigs between eight weeks and market age, though all ages can be affected when the disease enters a naive herd. The condition occurs globally wherever pigs are raised, with prevalence varying according to production practices, biosecurity standards, and regional control efforts. Some countries and regions have achieved elimination or very low prevalence through coordinated control programs, while the disease remains endemic in other areas. Subclinically infected carrier pigs play a crucial role in maintaining infection within herds and transmitting disease to new populations.

The economic impact of swine dysentery stems from multiple sources including mortality, reduced growth performance, treatment costs, and extended time to market weight. Mortality in untreated outbreaks can reach significant levels, particularly when diagnosis is delayed or antimicrobial resistance complicates treatment. Surviving pigs typically experience substantial reductions in average daily gain and feed efficiency, extending the finishing period and increasing production costs. Treatment expenses include medication costs, veterinary services, and increased labor for monitoring and managing affected groups. Additional losses may result from movement restrictions imposed during outbreak control efforts.

Early detection and prompt treatment are critical for minimizing swine dysentery impacts on affected herds. The disease is treatable with appropriate antimicrobial therapy, and elimination from infected herds is achievable through strategic medication combined with thorough cleaning and management changes. However, emergence of antimicrobial resistance among Brachyspira isolates in some regions has complicated treatment decisions and emphasizes the importance of prevention-focused approaches. Understanding the transmission dynamics, clinical presentation, and control options for swine dysentery enables producers and veterinarians to implement effective management programs that protect herd health and productivity.

Swine dysentery is caused by infection with Brachyspira hyodysenteriae, a Gram-negative anaerobic spirochete bacterium that colonizes the large intestine of pigs. This organism possesses specialized adaptations enabling it to penetrate the protective mucus layer of the colon and cecum where it causes direct tissue damage. The bacterium produces hemolysins and other virulence factors that contribute to the characteristic hemorrhagic lesions of the disease. Other Brachyspira species including Brachyspira hampsonii and strongly hemolytic variants of related species can cause similar clinical presentations, though B. hyodysenteriae remains the primary pathogen of concern.

Genetic and breed predisposition to swine dysentery appears minimal, with all pig breeds and genetic lines demonstrating susceptibility to infection when exposed to virulent organisms. Some research suggests possible variation in disease resistance among individuals, potentially related to differences in intestinal microbiome composition or mucosal immune responses, but practical implications for genetic selection remain limited. The disease affects commercial hybrid pigs, purebred animals, and heritage breeds without clear breed-specific patterns, indicating that management and biosecurity factors outweigh genetic influences in determining herd-level risk.

Environmental and management factors significantly influence swine dysentery transmission and persistence within pig populations. The organism survives for extended periods in moist fecal material and contaminated environments, with survival times exceeding two months reported under favorable conditions. Inadequate cleaning and disinfection between production groups allows environmental persistence that maintains infection across successive pig placements. Rodents, particularly mice, can become infected with B. hyodysenteriae and serve as reservoir hosts that maintain infection on premises even when pig populations are depopulated. Wild birds and other wildlife may also contribute to environmental contamination and disease spread between farms.

Risk factors for swine dysentery outbreaks include introduction of infected carrier pigs through purchases or returns, exposure to contaminated transport vehicles, and contact with contaminated boots, clothing, or equipment carried between farms. Stress factors including transportation, dietary changes, overcrowding, and temperature fluctuations can trigger clinical disease in subclinically infected carriers and increase severity in newly exposed pigs. Continuous flow production systems that maintain ongoing pig-to-pig contact facilitate transmission compared to all-in-all-out management with thorough cleaning between groups. Dietary composition influences disease expression, with certain fiber sources and feed forms affecting intestinal conditions relevant to Brachyspira colonization.

The pathophysiology of swine dysentery involves initial colonization of the large intestinal mucosa followed by progressive tissue destruction. After oral ingestion of contaminated feces or environmental material, B. hyodysenteriae organisms navigate to the cecum and colon where anaerobic conditions favor their growth. The spirochetes penetrate the mucus layer and associate closely with epithelial cells, where they produce cytotoxic factors including hemolysins that damage the intestinal lining. Progressive destruction of surface epithelium leads to erosion and ulceration with hemorrhage into the intestinal lumen. The resulting inflammatory response produces abundant mucus secretion that mixes with blood and necrotic debris to create the characteristic mucohemorrhagic feces. Disruption of normal colonic absorptive function contributes to the fluid loss and dehydration that accompany clinical disease.

Early warning signs of swine dysentery often precede the characteristic bloody diarrhea by several days, providing opportunity for early intervention when recognized. Initial signs include subtle changes in fecal consistency with softening of normal feces toward a looser texture. Affected pigs may show slight reductions in feed intake and marginally decreased activity levels that could easily be overlooked in group-housed animals. Some pigs develop a gaunt appearance with mild abdominal tucking before diarrhea becomes obvious. Careful observation of pens during cleaning may reveal increased moisture or abnormal fecal coloration before individual sick pigs are identified.

The hallmark symptom of swine dysentery is mucohemorrhagic diarrhea characterized by loose to watery feces containing variable amounts of blood and mucus. In typical cases, feces progress from soft and gray-colored to liquid consistency with obvious fresh blood and stringy mucus that may coat fecal material or appear separately. The blood content varies from streaks and flecks to frank hemorrhage producing distinctly red or dark tarry feces depending on the location and severity of intestinal lesions. Mucus production becomes pronounced as the disease progresses, with copious amounts of clear to whitish mucus mixed throughout fecal material or passed separately.

Behavioral changes accompany the physical symptoms of swine dysentery as affected pigs respond to intestinal discomfort and progressive illness. Sick pigs typically reduce feed consumption significantly and may stand near feeders without eating. Isolation from penmates is common, with affected animals seeking quiet areas away from group activity. Increased water consumption may occur as pigs attempt to compensate for fluid losses from diarrhea. Affected pigs often adopt a hunched posture with arched backs and appear reluctant to move or may resist handling. Vocalizations during defecation may indicate abdominal cramping and discomfort associated with the inflammatory process.

Physical signs beyond the characteristic diarrhea include progressive dehydration evidenced by sunken eyes, prominent backbone and hip bones as body condition deteriorates, and tacky mucous membranes. Skin may appear pale in significantly affected pigs due to ongoing blood loss. The perianal region typically shows heavy fecal staining with adhered material from frequent diarrhea episodes. Abdominal palpation may reveal gas distension and pain responses. Weight loss becomes apparent within days of clinical onset and may be substantial in pigs that survive extended illness. Body temperature may be normal or slightly elevated, distinguishing swine dysentery from many septicemic conditions that produce high fevers.

Symptom progression in untreated swine dysentery follows a pattern of increasing severity over days to weeks. Initial soft feces transition to watery diarrhea with increasing blood and mucus content. Dehydration and weakness progress as fluid losses continue and feed intake declines. Some pigs develop intermittent bloody diarrhea with periods of apparent improvement followed by relapse. Chronic cases may persist for weeks with continued weight loss and poor growth performance. Severely affected pigs may become recumbent from weakness before death, though mortality rates vary widely depending on host factors and environmental conditions.

Emergency symptoms requiring immediate veterinary intervention include sudden onset of profuse bloody diarrhea in multiple pigs suggesting acute outbreak in a naive population, severe dehydration with weakness and recumbency, prolapse of the rectum secondary to straining from diarrhea, and failure to respond to initial treatment attempts. High mortality rates within affected groups indicate aggressive disease requiring urgent reassessment of diagnosis and treatment protocols. The appearance of swine dysentery in a previously negative herd represents a biosecurity emergency requiring immediate investigation to identify the introduction source and prevent further spread within the operation.

Clinical examination of pigs with suspected swine dysentery focuses on characteristic findings that distinguish this condition from other causes of diarrhea. Physical examination reveals the pathognomonic mucohemorrhagic feces with fresh blood and copious mucus mixed throughout loose to watery fecal material. Assessment of body condition, hydration status, and overall demeanor helps determine disease severity and prognosis for individual animals. Examination of the pen environment often reveals blood-stained feces spread across flooring and walls from the frequent defecation of affected pigs. Recording the distribution of clinical signs within and across pens helps characterize outbreak patterns and identify potential introduction points.

Diagnostic testing for swine dysentery employs multiple laboratory methods to confirm the presence of pathogenic Brachyspira organisms. Traditional culture of fecal samples or colonic tissue on selective anaerobic media allows isolation and characterization of Brachyspira species, though the fastidious nature of these organisms requires specialized laboratory capabilities and extended incubation periods. Polymerase chain reaction testing offers rapid and sensitive detection of B. hyodysenteriae genetic material directly from clinical samples without culture requirements. Fluorescent antibody testing on intestinal tissue sections can demonstrate spirochetes within lesions at necropsy. Histopathological examination of colon and cecum reveals characteristic superficial mucosal necrosis with crypt elongation and inflammatory infiltrates.

Differential diagnosis for swine dysentery includes other infectious and non-infectious causes of bloody diarrhea and colitis in pigs. Salmonellosis can produce hemorrhagic enterocolitis with similar gross appearance, though distribution of lesions differs and the causative organisms are readily distinguished through culture. Proliferative hemorrhagic enteropathy caused by Lawsonia intracellularis produces bloody diarrhea primarily affecting the small intestine rather than the colon. Other Brachyspira species including B. pilosicoli cause milder colitis that may resemble early or resolving swine dysentery cases. Hemorrhagic bowel syndrome produces acute bloody intestinal content but with distinct clinical presentation and lesion distribution. Rectal examination and careful lesion assessment at necropsy help distinguish these conditions before laboratory confirmation.

Herd-level diagnostics extend beyond individual animal testing to assess population infection status and monitor control program effectiveness. Environmental sampling can detect Brachyspira contamination on surfaces, in manure pits, and in rodent populations that may serve as reservoirs. Monitoring of pen fecal consistency scores provides early warning of disease activity before clinical cases become obvious. Serological testing has limited utility for swine dysentery due to poor correlation between antibody status and current infection or disease susceptibility. Slaughter check programs examining colonic lesions provide feedback on subclinical disease that may not produce obvious clinical signs during the finishing period but still impacts growth performance.

Emergency treatment of acute swine dysentery outbreaks requires rapid implementation of antimicrobial therapy along with supportive care for severely affected individuals. Initial response should include separation of obviously ill pigs to hospital pens allowing individual monitoring and treatment while reducing shedding pressure on penmates. Fluid therapy addresses dehydration from ongoing diarrhea, with oral electrolyte solutions appropriate for pigs still drinking voluntarily while severely dehydrated animals may require parenteral fluid support. Maintaining environmental comfort through appropriate temperatures and clean dry bedding supports recovery efforts.

Medical management of swine dysentery centers on antimicrobial therapy targeting Brachyspira hyodysenteriae in the colonic environment. Effective antimicrobials historically include pleuromutilins such as tiamulin and valnemulin, carbadox (where still permitted), and lincomycin, though resistance patterns vary geographically and by isolate. Treatment typically involves water medication or feed medication for group treatment, with injection therapy reserved for individual pigs too ill to consume adequate medication through oral routes. Treatment duration generally extends ten to fourteen days for initial outbreak control, though protocols vary based on veterinary guidance and regional practices. All antimicrobial use must observe appropriate withdrawal times before slaughter and comply with veterinary feed directive requirements where applicable.

Surgical intervention for swine dysentery is limited to management of complications rather than treatment of the primary condition. Rectal prolapse secondary to straining from severe diarrhea occasionally requires surgical correction in valuable breeding animals, involving replacement of prolapsed tissue and pursestring suture placement to prevent recurrence. This complication carries guarded prognosis and affected market pigs are typically culled rather than treated surgically. The primary disease process responds to medical management rather than surgical approaches.

Supportive care complements antimicrobial therapy in managing swine dysentery cases and herds. Nutritional support through easily digestible feeds and ensured access to clean water promotes recovery and maintains body condition during treatment. Probiotic supplementation may help restore normal intestinal microflora following antimicrobial treatment. Reducing stocking density in affected pens decreases environmental contamination pressure and allows better individual monitoring. Environmental management including improved ventilation and temperature control reduces stress on recovering pigs. Concurrent treatment of any secondary bacterial infections helps prevent complications.

Herd treatment protocols aim to control active disease while reducing environmental contamination to enable elimination. Strategic pulse medication programs alternating treatment and withdrawal periods can reduce Brachyspira populations while allowing detection of persistent shedders during medication-free intervals. Coordinating medication with thorough cleaning and disinfection of facilities maximizes environmental organism reduction. Treatment of subclinically infected breeding stock may be necessary to eliminate reservoir populations. Rodent control concurrent with pig treatment addresses this important maintenance host. Documentation of treatment protocols, drug choices, and pig identification supports withdrawal time management and regulatory compliance.

Treatment decisions for swine dysentery balance therapeutic goals with economic and regulatory considerations inherent to food animal production. Individual treatment of severely affected pigs must consider their likelihood of recovery, the impact on marketing schedules from withdrawal time requirements, and labor costs of intensive care. Herd-level treatment decisions involve the costs of medication programs versus production losses from continued disease activity. Development of antimicrobial resistance among Brachyspira isolates in some regions has reduced treatment options and increased emphasis on prevention and elimination strategies rather than ongoing suppressive treatment. Veterinary guidance ensures appropriate drug selection based on susceptibility patterns and compliance with evolving regulations regarding antimicrobial use in food animals.

Recovery timelines for swine dysentery vary based on disease severity, treatment timing, and individual pig factors. Pigs with mild to moderate disease typically show clinical improvement within five to seven days of initiating appropriate antimicrobial therapy, with resolution of bloody diarrhea preceding full restoration of normal fecal consistency. Severely affected pigs may require two to three weeks before diarrhea fully resolves, and some individuals never return to normal intestinal function following extensive mucosal damage. Complete recovery of lost body weight and restoration of normal growth trajectories often requires three to six weeks beyond resolution of clinical signs as intestinal healing continues internally.

Post-treatment care and monitoring extend well beyond resolution of clinical symptoms to ensure disease control and identify persistent shedders. Fecal monitoring should continue throughout the recovery period to detect any relapse in previously treated animals. Weight gain tracking compared to unaffected cohort groups quantifies the production impact and recovery trajectory of individual pigs or affected groups. Environmental sampling following cleaning and disinfection confirms successful decontamination before restocking. Ongoing surveillance of the breeding herd identifies subclinical carriers that may perpetuate infection cycles.

Prognosis for individual pigs with swine dysentery depends on disease severity at treatment initiation and response to therapy. Pigs treated early in the disease course before severe dehydration and weight loss develop generally recover fully with appropriate management. Chronically affected pigs with extensive intestinal damage may survive but never achieve competitive growth performance. Complications including rectal prolapse, secondary bacterial infections, and severe protein loss carry guarded to poor prognosis. Population-level prognosis is generally good when comprehensive control programs are implemented, with elimination achievable through strategic medication combined with intensive cleaning and biosecurity measures.

Return to production considerations following swine dysentery outbreaks include assessment of recovered pig performance and herd infection status. Pigs that have recovered from clinical disease should be monitored for growth performance relative to unaffected contemporaries, with poor performers identified for potential early marketing. Breeding animals that have recovered require testing to confirm they are not persistent shedders before returning to production roles. Facilities must be confirmed free of environmental contamination before introducing naive replacement stock. Economic analysis of outbreak impacts informs decisions about control program investments and potential herd closure for elimination efforts.

Vaccination against swine dysentery has been investigated extensively but no consistently effective commercial vaccine is currently available in most markets. The challenges of developing protective immunity against mucosal infection with an extracellular spirochete have limited vaccine success. Research continues into novel vaccine approaches including outer membrane protein-based and live attenuated candidates. In the absence of effective vaccination, prevention relies heavily on biosecurity and management measures to prevent introduction and eliminate existing infection.

Biosecurity measures form the cornerstone of swine dysentery prevention and control programs. Purchasing replacement animals only from herds with documented negative status reduces introduction risk through this common pathway. Quarantine and testing of all incoming pigs before contact with the main herd allows detection of subclinically infected carriers. Vehicle sanitation protocols prevent transmission via contaminated transport trailers, loading chutes, and equipment shared between farms. Personnel biosecurity including farm-specific footwear, clothing changes, and shower-in policies prevents mechanical transmission through contaminated boots and clothing. Implementing a robust rodent control program eliminates this important reservoir host capable of maintaining infection on premises indefinitely.

Nutritional factors influence swine dysentery susceptibility and can be manipulated for preventive benefit. Inclusion of certain dietary fiber sources including inulin and resistant starch may alter intestinal fermentation patterns in ways unfavorable to Brachyspira colonization. Feed form affects transit time and intestinal conditions, with coarsely ground meal diets sometimes associated with reduced disease expression compared to finely ground pelleted feeds. Organic acids incorporated in feed or water may create intestinal pH conditions less favorable for spirochete survival. Zinc oxide supplementation during critical periods has shown some benefit in reducing disease severity, though environmental concerns may limit this practice.

Management practices significantly influence swine dysentery transmission dynamics within pig populations. All-in-all-out production with thorough cleaning and extended drying periods between groups is essential for breaking transmission cycles. Disinfection protocols must employ products effective against Brachyspira, with adequate contact time and thorough mechanical cleaning before disinfectant application. Maintaining separate equipment and personnel for different production areas prevents cross-contamination. Minimizing stress through consistent management, appropriate stocking densities, and environmental comfort reduces clinical disease expression in potentially exposed animals.

Quarantine and testing protocols are essential components of programs aimed at preventing introduction or achieving elimination of swine dysentery. Incoming pigs should be held in isolation facilities physically separated from the main herd for a minimum of thirty days while undergoing testing. PCR testing of fecal samples collected multiple times during quarantine provides sensitive detection of infected carriers. Semen and boar introductions require particular attention as breeding stock movements represent high-risk pathways for disease introduction. Regular monitoring of existing herd status through systematic sampling programs confirms ongoing freedom from infection and enables rapid response if disease is detected.

Daily management and monitoring of herds with swine dysentery history requires vigilant observation and consistent application of control protocols. Caretakers should examine fecal consistency in all pens during daily activities, looking for early signs of softening or abnormal coloration that might indicate disease recurrence. Observation of pig behavior including feed consumption, activity levels, and social interactions helps identify potential problems before clinical diarrhea becomes obvious. Recording observations systematically creates documentation supporting early detection and trend analysis over time.

Housing and environmental management significantly influence swine dysentery risk and should be optimized for prevention. Flooring systems that minimize fecal accumulation and allow rapid drying reduce environmental persistence of Brachyspira organisms. Adequate drainage prevents pooling of contaminated liquids that serve as infection reservoirs. Ventilation systems should maintain dry conditions while providing appropriate air quality for respiratory health. Temperature management avoids the stress of thermal extremes that may trigger clinical disease in subclinically infected animals. Physical separation between age groups prevents transmission from potentially infected older pigs to susceptible younger animals.

Herd health programs addressing swine dysentery integrate multiple prevention and monitoring components into comprehensive management approaches. Veterinary consultation helps design farm-specific protocols based on infection history, production system characteristics, and regional disease pressures. Regular review of health records, treatment frequency, and laboratory results guides program adjustments and identifies emerging problems. Coordination between breeding and growing operations ensures consistent control measures throughout production flows. Participation in regional control initiatives benefits from shared surveillance data and coordinated eradication efforts.

Record keeping and monitoring systems provide essential documentation for swine dysentery management programs. Treatment records track antimicrobial use for regulatory compliance and withdrawal time management. Mortality records categorized by clinical presentation help identify disease-related deaths even without laboratory confirmation of every case. Feed delivery and medication records support trace-back investigations and program evaluation. Growth performance data allows quantification of disease impacts and recovery assessment. Laboratory test results maintained chronologically document infection status changes and confirm elimination program success.

Economic considerations pervade swine dysentery management decisions at multiple levels. Prevention program costs including enhanced biosecurity infrastructure, testing expenses, and potential productivity impacts from management restrictions must be balanced against outbreak risks and consequences. Treatment costs during outbreaks encompass medication expenses, veterinary fees, increased labor, and lost productivity from affected pigs. Long-term economic analysis often favors investment in elimination programs that remove ongoing disease pressure over continuous management of endemic infection. Producers working with veterinarians and financial advisors can optimize control program investments to maintain profitability while protecting animal welfare and productivity.

All swine breeds demonstrate susceptibility to swine dysentery when exposed to virulent Brachyspira hyodysenteriae organisms, with no breed exhibiting complete resistance to infection or clinical disease. Commercial hybrid pigs developed for intensive production systems appear neither more nor less susceptible than purebred animals or heritage breeds, indicating that breed-specific factors play minimal role in disease risk. Individual variation in disease resistance likely exists within populations, potentially related to intestinal microbiome composition, mucosal immune function, or other host factors, but practical implications for breed selection remain undefined.

Production type considerations influence swine dysentery management approaches more than breed selection. Farrow-to-finish operations must address disease risks across all production stages from breeding herds through finishing, requiring comprehensive control programs spanning the entire production cycle. Operations purchasing weaner pigs from multiple sources face particular challenges as each source represents a potential introduction pathway requiring biosecurity scrutiny. Breeding stock operations bear responsibility for maintaining negative status and preventing transmission to customer herds through rigorous testing and monitoring programs. Niche production systems including pastured or organic operations may face unique challenges from potential wildlife exposure while having limited antimicrobial treatment options.

Genetic selection and testing programs offer limited application for swine dysentery control compared to management-based approaches. While research has explored genetic variation in disease susceptibility and immune responses to Brachyspira infection, no practical genetic markers or selection tools have achieved commercial implementation. Testing programs focus on identifying and eliminating infected animals rather than selecting for resistance traits. Breeding herd surveillance through periodic fecal testing allows identification and removal of carrier animals before they transmit infection to offspring or contaminate farrowing facilities. The emphasis in genetic programs remains on eliminating the pathogen rather than developing resistant pig populations.

Commonly co-occurring conditions with swine dysentery include other enteric infections that share transmission pathways or predisposing factors. Salmonellosis may occur concurrently, particularly in herds experiencing multiple biosecurity challenges, and can complicate clinical presentation and diagnosis. Proliferative enteropathy caused by Lawsonia intracellularis frequently affects the same age groups and may be present simultaneously, though lesion distribution differs. Intestinal parasitism including whipworm and coccidia infections can exacerbate clinical disease severity and complicate recovery when present alongside Brachyspira infection. Respiratory diseases including porcine reproductive and respiratory syndrome and swine influenza may increase susceptibility to enteric infections through immunosuppression.

Conditions with similar clinical presentations to swine dysentery require careful differentiation for appropriate treatment. Salmonella typhimurium infection can produce bloody diarrhea resembling swine dysentery, though fever patterns and lesion distribution typically differ. Proliferative hemorrhagic enteropathy presents with sudden bloody diarrhea in older finishing pigs but primarily affects the ileum rather than the colon. Other Brachyspira species including B. pilosicoli cause porcine intestinal spirochetosis with milder colitis that may resemble early or resolving swine dysentery. Hemorrhagic bowel syndrome produces acute bloody intestinal content but with distinct presentation and course. Dietary factors including excessive fiber or feed changes can cause transient loose feces requiring differentiation from infectious causes.

Complications and sequelae following swine dysentery affect both individual recovery and population-level productivity. Rectal prolapse develops in some severely affected pigs due to persistent straining and loss of perirectal tissue integrity. Secondary bacterial infections may colonize damaged intestinal mucosa, prolonging illness and complicating recovery. Chronic poor-doers result when intestinal damage prevents restoration of normal absorptive function. Persistent carrier states establish ongoing infection reservoirs that maintain disease within herds and threaten reintroduction following apparent elimination. Understanding these potential sequelae guides treatment decisions, recovery expectations, and control program design.